iCor has a consolidated track record focused on the comprehensive approach to cardiac diseases, especially myocardial infarction and heart failure, combining basic, translational and clinical research. Its activity is focused on the search for innovative solutions for the regeneration of cardiac tissue through cell therapies, biomaterials and advanced tissue engineering techniques.

From this perspective, the group has promoted pioneering studies in humans through clinical trials that have allowed strategies developed in the laboratory to be transferred to the clinical field, including the implantation of biological structures in the damaged heart after a heart attack. Clinical research is an essential part of its work, with a focus on the design, execution and monitoring of clinical trials aimed at evaluating new therapies and improving medical practice in the cardiovascular field.